Diversity of reporter expression patterns in transgenic mouse lines targeting corticotropin- releasing hormone-expressing neurons

Endocrinology

Volumn 156, Issue 12, 2015, Pages 4769-4780

  Chen, Yuncai ^a   Molet, Jenny ^a   Gunn, Benjamin G ^a   Ressler, Kerry ^b   Baram, Tallie Z ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISERUM; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTIBODY; HORMONE ANTIBODY; UNCLASSIFIED DRUG; GREEN FLUORESCENT PROTEIN; INTERNAL RIBOSOME ENTRY SITE; MESSENGER RNA; TRANSCRIPTOME;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN REGION; CELL HETEROGENEITY; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; CRFP3 0CREGFP TRANSGENIC MOUSE; CRH GFP BAC TRANSGENIC MOUSE; CRH IRES CRE AI14 TDTOMATO TRANSGENIC MOUSE; GENE EXPRESSION; GENETIC VARIABILITY; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; MALE; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; REPORTER GENE; SALIENCE NETWORK; STRAIN DIFFERENCE; STRESS; TRANSGENIC MOUSE; WILD TYPE; AMYGDALA; ANIMAL; BRAIN; CYTOLOGY; GENETICS; HIPPOCAMPUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HYPOTHALAMUS; INTERNAL RIBOSOME ENTRY SITE; METABOLISM; SEPTUM NUCLEUS;

AMYGDALA; ANIMALS; BRAIN; CORTICOTROPIN-RELEASING HORMONE; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; HYPOTHALAMUS; INTERNAL RIBOSOME ENTRY SITES; MALE; MICE; MICE, TRANSGENIC; NEURONS; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RNA, MESSENGER; SEPTAL NUCLEI; TRANSCRIPTOME;

EID: 84948173529     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1673     Document Type: Article

References (56)

1. Atasoy D, Betley JN, Su HH, Sternson SM. Deconstruction of a neural circuit for hunger. Nature. 2012;488:172-177.
2. Jennings JH, Sparta DR, Stamatakis AM, et al. Distinct extended amygdala circuits for divergent motivational states. Nature. 2013; 496:224-228.
3. Lammel S, Lim BK, Ran C, et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature. 2012;491:212-217.
4. Haettig J, Sun Y, Wood MA, Xu X. Cell-type specific inactivation of hippocampalCA1disrupts location-dependent object recognition in the mouse. Learn Mem. 2013;20:139-146.
5. Chaudhury D, Walsh JJ, Friedman AK, et al. Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons. Nature. 2013;493:532-536.
6. Kolber BJ, Boyle MP, Wieczorek L, et al. Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice. J Neurosci. 2010;30: 2571-2581.
7. Lu A, Steiner MA, Whittle N, et al. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol Psychiatry. 2008;13:1028-1042.
8. Regev L, Tsoory M, Gil S, Chen A. Site-specific genetic manipulation of amygdala corticotropin-releasing factor reveals its imperative role in mediating behavioral response to challenge. Biol Psychiatry. 2012;71:317-326.
9. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci. 1994;14:2579-2584.
10. Sakanaka M, Shibasaki T, Lederis K. Distribution and efferent pro-jections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res. 1986;382:213-238.
11. Chen Y, Bender RA, Frotscher M, Baram TZ. Novel and transient populations of corticotropin-releasing hormone-expressing neurons in developing hippocampus suggest unique functional roles: a quantitative spatiotemporal analysis. J Neurosci. 2001;21:7171-7181.
12. Yan XX, Toth Z, Schultz L, Ribak CE, Baram TZ. Corticotropinreleasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus. 1998;8:231-243.
13. Nguyen AQ, Xu X. Characterization of specific neuronal types in the bed nucleus of the stria terminalis aided by using multiple transgenic mouse lines. Annual Meeting of the Society for Neuroscience, Washington, DC, 2014, Program 391.02 (Abstract).
14. Taniguchi H, He M, Wu P, et al. A resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex. Neuron. 2011;71:995-1013.
15. Alon T, Zhou L, Pérez CA, Garfield AS, Friedman JM, Heisler LK. Transgenic mice expressing green fluorescent protein under the control of the corticotropin-releasing hormone promotor. Endocrinology. 2009;150:5626-5632.
16. Sarkar J, Wakefield S, MacKenzie G, Moss SJ, Maguire J. Neurosteroidogenesis is required for the physiological response to stress: role of neurosteroid-sensitive GABAA receptors. J Neurosci. 2011; 21:18198-18210.
17. Hooper A, Maguire J. Characterization of a novel subtype of hippocampal interneurons that express corticotropin-releasing hormone. Hippocampus. doi: 10.1002/hipo.22487. Published online ahead of print July 1, 2015.
18. Martin EI, Ressler KJ, Jasnow AM, et al. A novel transgenic mouse for gene-targeting within cells that express corticotropin-releasing factor. Biol Psychiatry. 2010;67:1212-1216.
19. Regev L, Ezrielev E, Gershon E, Gil S, Chen A. Genetic approach for intracerebroventricular delivery. Proc Natl Acad Sci USA. 2010; 107:4424-4429.
20. Wamsteeker Cusulin JI, Füzesi T, Watts AG, Bains JS. Characterization of corticotropin-releasing hormone neurons in the paraventricular nucleus of the hypothalamus of Crh-IRES-Cre mutant mice. Plos One. 2013;8:e64943.
21. Joëls M, Baram TZ. The neurosymphony of stress. Nat Rev Neurosci. 2009;10:459-466.
22. Gafford GM, Ressler KJ. GABA and NMDA receptors in CRF neurons have opposing effects in fear acquisition and anxiety in central amygdala vs. bed nucleus of the stria terminalis. Horm Behav. Published online ahead of print April 14, 2015. doi: 10.1016/j. yhbeh.2015.04.001.
23. Chen Y, Rex CS, Rice CJ, et al. Correlated memory defects and hippocampal dendritic spine loss after acute stress involve corticotropin- releasing hormone signaling. Proc Natl Acad Sci USA. 2010; 107:13123-13128.
24. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA. 2002;99:13908-13913.
25. Grieder TE, Herman MA, Contet C, et al. VTA CRF neurons mediate the aversive effects of nicotine withdrawal and promote intake escalation. Nat Neurosci. 2014;17:1751-1758.
26. Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 2014;35:234-244.
27. Tiscornia G, Tergaonkar V, Galimi F, Verma IM. CRE recombinase- inducible RNA interference mediated by lentiviral vectors. Proc Natl Acad Sci USA. 2004;101:7347-7351.
28. Gong S, Zheng C, Doughty ML, et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature. 2003;425:917-925.
29. Yang XW, Model P, Heintz N. Homologous recombination based modification in Escherichia coli and germline transmission in transgenic mice of a bacterial artificial chromosome. Nat Biotechnol. 1997;15:859-865.
30. Chen Y, Brunson KL, Adelmann G, Bender RA, Frotscher M, Baram TZ. Hippocampal corticotropin releasing hormone: pre- and postsynaptic location and release by stress. Neuroscience. 2004;126: 533-540.
31. Sawchenko PE, Swanson LW, Vale WW. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J Neurosci. 1984;4:1118-1129.
32. Chen Y, Andres AL, Frotscher M, Baram TZ.Tuning synaptic transmission in the hippocampus by stress: the CRH system. Front Cell Neurosci. 2012;6:13.
33. Saper CB, Sawchenko PE. Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol. 2003 465:161-163.
34. Swanson LW, Sawchenko PE, Lind RW. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog Brain Res. 1986;68:169-190.
35. Biag J, Huang Y, Gou L, et al. Cyto- and chemoarchitecture of the hypothalamic paraventricular nucleus in the C57BL/6J male mouse: a study of immunostaining and multiple fluorescent tract tracing. J Comp Neurol. 2012;520:6-33.
36. Yan XX, Baram TZ, Gerth A, Schultz L, Ribak CE. Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons. Exp Brain Res. 1998;123:334-340.
37. Sakanaka M, Shibasaki T, Lederis K. Corticotropin releasing factorlike immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. J Comp Neurol. 1987;260:256-298.
38. Rho JH, Swanson LW. A morphometric analysis of functionally defined subpopulations of neurons in the paraventricular nucleus of the rat with observations on the effects of colchicine. J Neurosci. 1989;9:1375-1388.
39. Keegan CE, Karolyi IJ, Knapp LT, Bourbonais FJ, Camper SA, Seasholtz AF. Expression of corticotropin-releasing hormone transgenes in neurons of adult and developing mice. Mol Cell Neurosci. 1994;5:505-514.
40. Gafford GM, Guo JD, Flandreau EI, Hazra R, Rainnie DG, Ressler KJ. Cell-type specific deletion of GABA(A)α1 in corticotropin-releasing factor-containing neurons enhances anxiety and disrupts fear extinction. Proc Natl Acad Sci USA. 2012;109:16330-16335.
41. Korosi A, Baram TZ. The central corticotropin releasing factor system during development and adulthood. Eur J Pharmacol. 2008; 583:204-214.
42. Pleil KE, Rinker JA, Lowery-Gionta EG, et al.NPYsignaling inhibits extended amygdala CRF neurons to suppress binge alcohol drinking. Nat Neurosci. 2015;18:545-552.
43. Bale TL, Lee KF, Vale WW. The role of corticotropin-releasing factor receptors in stress and anxiety. Integr Comp Biol. 2002;42: 552-555.
44. Hayley S, Staines W, Merali Z, Anisman H. Time-dependent sensitization of corticotropin-releasing hormone, arginine vasopressin and c-fos immunoreactivity within the mouse brain in response to tumor necrosis factor-α. Neuroscience. 2001;106:137-148.
45. Beckerman MA, Van Kempen TA, Justice NJ, Milner TA, Glass MJ. Corticotropin-releasing factor in the mouse central nucleus of the amygdala: ultrastructural distribution in NMDA-NR1 receptor subunit expressing neurons as well as projection neurons to the bed nucleus of the stria terminalis. Exp Neurol. 2013;239:120-132.
46. Dubé CM, Molet J, Singh-Taylor A, Ivy A, Maras PM, Baram TZ. Hyper-excitability and epilepsy generated by chronic early-life stress. Neurobiol Stress. 2015;2:10-19.
47. Choi DC, Furay AR, Evanson NK, Ostrander MM, Ulrich-Lai YM, Herman JP. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J Neurosci. 2007;27: 2025-2034.
48. McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc Natl Acad Sci USA. 2006;103:18267-18272.
49. Ivy AS, Rex CS, Chen Y, et al. Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. J Neurosci. 2010;30:13005-13015.
50. Seasholtz AF, Thompson RC, Douglass JO. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin- releasing hormone gene. Mol Endocrinol. 1988;2:1311-1319.
51. Baram TZ, Lerner SP. Ontogeny of corticotropin releasing hormone gene expression in rat hypothalamus-comparison with somatostatin. Int J Dev Neurosci. 1991;9:473-478.
52. Grino M, Young WS 3rd, Burgunder JM. Ontogeny of expression of the corticotropin-releasing factor gene in the hypothalamic paraventricular nucleus and of the proopiomelanocortin gene in rat pituitary. Endocrinology. 1989;124:60-68.
53. Lammel S, Steinberg EE, Földy C, et al. Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons. Neuron. 2015;85:429-438.
54. Harris JA, Hirokawa KE, Sorenson SA, et al. Anatomical characterization of Cre driver mice for neural circuit mapping and manipulation. Front Neural Circuits. 2014;8:76.
55. Gunn BG, Cunningham L, Cooper MA, et al. Dysfunctional astrocytic and glutamtergic regulation of hypothalamic glutamatergic transmission in a mouse model of early-life adversity: relevance to neurosteroids and programming of the stress response. J Neurosci. 2013;33:19534-19554.
56. Hörtnagl H, Tasan RO, Wieselthaler A, Kirchmair E, Sieghart W, Sperk G. Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain. Neuroscience. 2013;236:345-372.